EDGEWISE THERAPEUTICS INC (EWTX)
US28036F1057 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 30.26M | 86.10M | 22.00M | 15.60M | 104.90M | |||
| Marketable Securities | 502.50M | 232.30M | 330.00M | 265.20M | 24.20M | |||
| Other Current Assets | 8.67M | 8.60M | 5.10M | 3.00M | 600.00K | |||
| Total Current Assets | 541.43M | 327.00M | 357.00M | 283.80M | 129.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 12.38M | 12.69M | 9.90M | 900.00K | 500.00K | |||
| Other Non-Current Assets | N/A | 348.00K | 300.00K | 500.00K | 1.00M | |||
| Total Non-Current Assets | 12.38M | 13.04M | 10.10M | 1.40M | 1.50M | |||
| TOTAL ASSETS | 553.81M | 340.04M | 367.10M | 285.20M | 131.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 9.88M | 12.75M | 10.50M | 6.70M | 2.80M | |||
| Accounts Payable | 4.72M | 4.03M | 6.10M | 3.80M | 1.60M | |||
| Total Current Liabilities | 14.60M | 16.77M | 16.60M | 10.50M | 4.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.26M | 4.43M | 3.80M | 300.00K | N/A | |||
| Total Non-Current Liabilities | 4.26M | 4.43M | 3.80M | 400.00K | 0.00 | |||
| TOTAL LIABILITIES | 18.86M | 21.20M | 20.40M | 10.90M | 4.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -273.29M | -244.76M | -144.60M | -77.00M | -34.10M | |||
| Additional Paid In Capital | 809.08M | 563.49M | 492.70M | 351.90M | 700.00K | |||
| Common Shares | 9.00K | 7.00K | 0.00 | 0.00 | 160.20M | |||
| Other Shareholders' Equity | -861.00K | 99.00K | -1.40M | -500.00K | N/A | |||
| Shares Outstanding | 93.28M | 70.45M | 63.30M | 49.50M | 47.60M | |||
| Tangible Book Value per Share | 5.73 | 4.53 | 5.48 | 5.54 | -0.70 | |||
| Total Shareholders' Equity | 534.94M | 318.83M | 346.70M | 274.40M | 126.80M | |||
| TOTAL LIABILITIES AND EQUITY | 553.81M | 340.04M | 367.10M | 285.20M | 131.10M | |||
| Statistics | ||||||||
| Current Ratio | 37.08 | 19.50 | 21.51 | 27.03 | 30.14 | |||
| Return On Assets (ROA) | -19.11% | -29.46% | -18.43% | -15.01% | -13.06% | |||
| Return On Equity (ROE) | -19.79% | -31.42% | -19.51% | -15.60% | -13.50% | |||
All data in USD